Back to Search Start Over

OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis

Authors :
Eli Muchtar
Stefan Schönland
Michaela Liedtke
Morie A. Gertz
Brendan Wisniowski
Paolo Milani
Oliver C Cohen
Shaji Kumar
Ronald Witteles
Meletios-Athanasios Dimopoulos
Suzanne Lentzsch
Giampaolo Merlini
Ute Hegenbart
Raphael Szalat
Efstathios Kastritis
Vaishali Sanchorawala
J. Bladé
Angela Dispenzieri
Heather Landau
Nelson Leung
Kaya Veelkan
Giovanni Palladini
Darren Foard
MT Cibeira
Ashutosh D. Wechalekar
Source :
Clinical Lymphoma Myeloma and Leukemia. 21:S23-S24
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Background Renal light chain (AL) amyloidosis manifests as proteinuria with or without renal failure and is associated with a risk of progression to renal replacement therapy (RRT). A significant reduction in circulating amyloidogenic light chain is needed to achieve a renal response. Current renal response criteria are binary defining a renal response as >30% reduction in 24-h proteinuria without worsening estimated glomerular filtration rate (eGFR). Several studies suggest that greater reduction in proteinuria following successful therapy improves renal and overall survival. Methods AL amyloidosis patients diagnosed between 2010 to 2015, achieving at least hematological partial response to therapy and with renal involvement were included. Four renal response categories were formulated based on reduction level in pretreatment 24-h proteinuria in the absence of renal progression: renal complete response (renCR, 24-h proteinuria ≤200 mg/24-h); renal very good partial response (renVGPR, >60% reduction in 24-h proteinuria); renal partial response (renPR, 31-60% reduction in 24-proteinuria); and renal no response (renNR, 30% or less reduction). Renal response was assessed at landmark (6-, 12-, and 24 months from treatment initiation) and as best renal response. Graded renal responses were assessed as predictors for time from diagnosis to RRT and overall survival. Results Seven hundred and thirty-seven patients were included. The median age was 63. Renal stage I, II and III were assigned to 34%, 52% and 14% of patients, respectively. Reduction in 24-h proteinuria from baseline improved over time with a median reduction of 34%, 50% and 71%, at 6-month, 12-month and 24-months, respectively. At best response, renCR, renVGPR, renPR and renNR were achieved in 27%, 34%, 15% and 24% of patients, respectively. A renal response as early as 6 months after therapy initiation was able to predict time to RRT with an increase in RRT risk with lower level of renal response at that time point (5-year RRT 0%, 3%, 9% and 16% for renCR, renVGPR, renPR and renNR, respectively, P Conclusions We validated new graded renal response criteria based on reduction in 24-h proteinuria. These 4-level renal response criteria highlight the importance of achieving a deep renal response to improve renal and overall survival. These findings will allow clinicians to make decision on therapy changes or augmentation based on response depth as early as 6-month before irreversible renal failure has developed.

Details

ISSN :
21522650
Volume :
21
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........26d6c9b389d2d9aa32197a383e977de6
Full Text :
https://doi.org/10.1016/s2152-2650(21)02110-8